CEVEC Pharmaceuticals Opens US Subsidiary
„The largest global Life Science market is the United States“ stated Dr. Rainer Lichtenberger, CEO of CEVEC. „ Since we have now a significant number of license holders based in the US, the new expansion will allow us to provide high quality, fast and very focused customer service".
Wolfgang Kintzel, CCO of CEVEC added: „Gary Boch, VP Business Development, North America, a very experienced Life Science professional, will manage our US business. From Maryland (US) we will now have the chance to further establish the CAP technology as a key protein expression platform being closer to our key customers and business partners.“
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.